Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Clinical Trials of Chiauranib Capsules

About this update from Shenzhen Chipscreen Biosciences Co. Ltd. Class A

Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Clinical Trials of Chiauranib Capsules The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Shenzhen Chipscreen Biosciences Co. Ltd. Class A